Related Experiment Video
Updated: May 21, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Finding a better drug for epilepsy: antiinflammatory targets
Stefanie Dedeurwaerdere1, Alon Friedman, Paolo F Fabene
1Translational Neuroscience, University of Antwerp, Antwerp, Belgium. stefanie.dedeurwaerdere@ua.ac.be
Inflammation and epilepsy are linked through complex signaling pathways. Understanding these inflammatory molecules offers potential for new epilepsy treatments and prevention strategies.
Area of Science:
- Neurobiology
- Epileptology
- Immunology
Background:
- Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
- Inflammation is increasingly recognized as a significant factor in epilepsy development and progression.
- Existing research indicates a complex interplay between inflammatory processes and epileptogenesis.
Purpose of the Study:
- To critically review the current understanding of inflammation's role in epilepsy.
- To explore the contribution of specific inflammatory molecules to epilepsy onset, progression, and comorbidities.
- To discuss the challenges and opportunities in targeting inflammatory pathways for epilepsy treatment.
Main Methods:
- Summary of discussions from the XI Workshop on Neurobiology of Epilepsy (WONOEP).
- Critical review of existing scientific literature on neuroinflammation and epilepsy.
- Analysis of signal-transduction pathways involved in inflammatory processes.
Main Results:
- Evidence suggests a coexistence of inflammatory processes and epileptogenesis via distinct signal-transduction pathways.
- Specific inflammatory molecules contribute to epilepsy onset, progression, and associated morbidities like depression.
- Complex cross-talk exists between inflammatory pathways, with mediators having differential roles in neurons versus other cell types.
Conclusions:
- The intricate nature of inflammatory pathways presents challenges for therapeutic development.
- Inflammatory molecules represent promising, yet complex, targets for epilepsy prevention and treatment.
- Further research is needed to elucidate the precise roles of specific mediators in neuronal and non-neuronal cells.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

